Medavail Holdings Inc 's Revenue in the fiscal year 2022 $ 43.11 millions
Medavail Holdings Inc 's Revenue in the fiscal year 2021 $ 22.13 millions
Medavail Holdings Inc 's Revenue in the fiscal year 2020 $ 13.97 millions
Medavail Holdings Inc 's Revenue in the fiscal year 2019 $ 1.03 millions
Medavail Holdings Inc 's Revenue in the fiscal year 2018 $ 0.36 millions
MDVL Revenue second quarter 2023 Y/Y Growth Comment
Medavail Holdings Inc reported fall in Revenue in the second quarter 2023 by -25% to $ 0.41 millions, from the same quarter in 2022. The drop in the second quarter 2023 Medavail Holdings Inc 's Revenue compares unfavorably to the Company's average Revenue doubling of 368.58%.
Looking into second quarter 2023 results within Pharmacy Services & Retail Drugstore industry 14 other companies have achieved higher Revenue growth. While Medavail Holdings Inc ' s Revenue drop of -25% ranks overall at the positon no. 4102 in the second quarter 2023.
MDVL Revenue ( Y/Y Growth %)
2023
2022
2021
2020
4th Quarter
December
-
55.91 %
-43.39 %
3284.21 %
3rd Quarter
September
-
97.93 %
-19.02 %
1942.86 %
2nd Quarter
June
-25 %
-89.26 %
117.75 %
1440 %
1st Quarter
March
129.63 %
-93.3 %
185.82 %
840 %
FY
-
6.73 %
-6.74 %
-
Financial Statements
Medavail Holdings Inc 's second quarter 2023 Revenue
Revenue by Quarter for the Fiscal Years 2020, 2021, 2022, 2023
Medavail Holdings Inc 's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
2552.37 %
140.91 %
-94.54 %
(Dec 31 2020)
MDVL's II. Quarter Q/Q Revenue Comment
In the II. Quarter 2023 Medavail Holdings Inc disclosed fall in Revenue from the first quarter by -34.68% to $ 0.41 millions, from $ 0.62 millions achived in the previous reporting period.
Although periodic circumstance commonly energize II. Quarter 2023 Revenue, this plainly could not be substantial to rescue Pharmacy Services & Retail Drugstore's company achievement, Most analysts pointed out.
Within Pharmacy Services & Retail Drugstore industry 14 other companies have achieved higher Revenue quarter on quarter growth. While Medavail Holdings Inc 's Revenue growth quarter on quarter, overall rank is 3902.
In the II. Quarter 2023 Medavail Holdings Inc disclosed fall in Revenue from the first quarter by -34.68% to $ 0.41 millions, from $ 0.62 millions achived in the previous reporting period.
Although periodic circumstance commonly energize II. Quarter 2023 Revenue, this plainly could not be substantial to rescue Pharmacy Services & Retail Drugstore's company achievement, Most analysts pointed out.
Within Pharmacy Services & Retail Drugstore industry 14 other companies have achieved higher Revenue quarter on quarter growth. While Medavail Holdings Inc 's Revenue growth quarter on quarter, overall rank is 3902.
Medavail Holdings Inc 's 12 Months Revenue Growth Year on Year
Revenue TTM Growth
12 Months Ending (Jun 30 2023)
12 Months Ending (Mar 31 2023)
12 Months Ending (Dec 31 2022)
12 Months Ending (Sep 30 2022)
12 Months Ending (Jun 30 2022)
Cumulative Revenue 12 Months Ending
$ 23.84
$ 23.97
$ 23.62
$ 19.55
$ 13.88
Y / Y Revenue Growth (TTM)
71.73 %
30.53 %
6.73 %
-29.46 %
-52.25 %
Year on Year Revenue Growth Overall
Ranking
# 494
# 408
# 409
# 653
# 665
Seqeuential Revenue Change (TTM)
-0.58 %
1.5 %
20.82 %
40.84 %
-24.43 %
Seq. Revenue Growth (TTM) Overall
Ranking
# 948
# 972
# 3162
# 354
# 356
Cumulative Revenue growth Comment
Although Medavail Holdings Inc 's Annual Revenue growth year on year were below company's average 212.28% , Revenue announced in the Jun 30 2023 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 71.73% year on year, from 30.53% in Mar 31 2023. And, Medavail Holdings Inc had the highest Revenue growth, in Pharmacy Services & Retail Drugstore industry.
Among companies within the Retail sector 13 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 408 to 494.
Although Medavail Holdings Inc 's Annual Revenue growth year on year were below company's average 212.28% , Revenue announced in the Jun 30 2023 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 71.73% year on year, from 30.53% in Mar 31 2023. And, Medavail Holdings Inc had the highest Revenue growth, in Pharmacy Services & Retail Drugstore industry.
Among companies within the Retail sector 13 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 408 to 494.
About Medavail Holdings Inc Revenue Growth Rates (MDVL), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.